Response to Comment on: Greenbaum et al. Through the Fog: Recent Clinical Trials to Preserve β-Cell Function in Type 1 Diabetes. Diabetes 2012;61:1323–1330

Registos relacionados

• Comment on: Greenbaum et al. Through the Fog: Recent Clinical Trials to Preserve β-Cell Function in Type 1 Diabetes. Diabetes 2012;61:1323–1330
  Por: Vialettes, Bernard, et al.
  Publicado em: (2012)
• Through the Fog: Recent Clinical Trials to Preserve β-Cell Function in Type 1 Diabetes
  Por: Greenbaum, Carla J., et al.
  Publicado em: (2012)
• Response to Comment on: Greenbaum et al. Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data. Diabetes 2012;61:2066–2073
  Por: Greenbaum, Carla J., et al.
  Publicado em: (2013)
• Comment on: Atkinson. It's Time to Consider Changing the Rules: The Rationale for Rethinking Control Groups in Clinical Trials Aimed at Reversing Type 1 Diabetes. Diabetes 2011;60:361–363
  Por: Sanda, Srinath, et al.
  Publicado em: (2011)
• Comment on: Greenbaum et al. Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data. Diabetes 2012;61:2066–2073
  Por: Rios, Paola, et al.
  Publicado em: (2013)